Fundraising Fox

CHASE Pharmaceuticals

Washington, US · Delaware corporation · 2 known investors

Biotech

Founders & leadership

NG
Nayan Greg ParekhDirector
KN
Karoly NikolichDirector
KC
Kathleen Clarence-SmithExecutive Officer
DI
Douglas IngramExecutive Officer, Director
TN
Thomas N. ChaseExecutive Officer, Director
SC
Stephen CunninghamDirector
VS
Vikram SudarsanDirector
JM
John M. ReherDirector
RW
Raphael WisniewskiDirector

Investors · 2

Andera PartnersParis
Brain Trust Accelerator FundreportedBurlingamevia John M. Reher · board

Reported raises · per SEC filings

Form D private placements
▶$12MraisedMar 2016 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathleen Clarence-SmithExecutive Officer
  • Vikram SudarsanDirector
  • Raphael WisniewskiDirector
  • Stephen CunninghamDirector
  • Nayan Greg ParekhDirector
  • Karoly NikolichDirector
  • John M. ReherDirector
  • Thomas N. ChaseExecutive Officer, Director
Offering amount
$12M
Amount sold
$12M
First sale
Mar 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedFeb 2016 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Raphael WisniewskiDirector
  • Vikram SudarsanDirector
  • Stephen CunninghamDirector
  • Nayan Greg ParekhDirector
  • John M. ReherDirector, Executive Officer
  • Thomas N. ChaseExecutive Officer, Director
  • Karoly NikolichDirector
  • Douglas IngramDirector
  • Kathleen Clarence-SmithExecutive Officer
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$106.7KofferedFeb 2016 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen CunninghamDirector
  • Raphael WisniewskiDirector
  • Vikram SudarsanDirector
  • Nayan Greg ParekhDirector
  • John M. ReherDirector
  • Thomas N. ChaseExecutive Officer, Director
  • Karoly NikolichDirector
  • Kathleen Clarence-SmithExecutive Officer
  • Douglas IngramExecutive Officer, Director
Offering amount
$106.7K
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$612.5KofferedFeb 2016 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Nayan Greg ParekhDirector
  • Karoly NikolichDirector
  • Kathleen Clarence-SmithExecutive Officer
  • John M. ReherDirector
  • Raphael WisniewskiDirector
  • Douglas IngramExecutive Officer, Director
  • Thomas N. ChaseExecutive Officer, Director
  • Stephen CunninghamDirector
  • Vikram SudarsanDirector
Offering amount
$612.5K
First sale
Jan 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.